|
Enlarge font
Reduce font
GSK to test Aposense technology in oncology studies
GlaxoSmithKline will evaluate the potential of Aposense's PET tracer ML-10 in monitoring drug activity in clinical studies of cancer therapies.
Globes correspondent10 Jun 09 13:15
For the whole article please click here.
|
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
feeds
HomeMarket prices | Site map | Newsletters | Israel links | About us | Support | Report Faults | Advertise | Archive | 
Home | News | Analysis | Features | Technology guide | Real estate | Israel in depth | International
Application delivery by 